Described herein are pharmaceutical packaging methods which stop oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive drugs, such devices which includes a syringe by having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with incredibly lower permeability to oxygen and compr